C. Duron

Increased factor VIII plays a significant role in plasma hypercoagulability phenotype of patients with cirrhosis

A. Lebreton, T. Lecompte, G. Lamblin, 2018, Journal of thrombosis and haemostasis : JTH.

Plasma hypercoagulability in the presence of thrombomodulin but not of activated protein C in patients with cirrhosis

A. Lebreton, G. Lamblin, A. Abergel, 2017, Journal of gastroenterology and hepatology.

Separation of zinc ligands in human seminal plasma

A. Favier, G. Decoux, J. Lafond, 1986, Biological Trace Element Research.

Factors influencing acute infusion reactions in inflammatory bowel disease patients treated with infliximab in the era of scheduled maintenance therapy

M. Goutte, A. Buisson, G. Bommelaer, 2015, European journal of gastroenterology & hepatology.

Extrahepatic portal vein obstruction (EHPVO) in cirrhosis.

D. Valla, C. Bureau, A. Lebreton, 2020, Clinics and research in hepatology and gastroenterology.

Low sensitivity to thrombomodulin in patients with cirrhosis; Impact of factor VIII increase and protein C deficiency

A. Lebreton, M. Berger, L. Muti, 2017 .

DOP013 Definition of therapeutic response criteria using MRI in Crohn's disease patients treated with anti-TNF therapy: a multicenter prospective study (the IRMA study).

M. Dapoigny, G. Bouguen, M. Goutte, 2017, Journal of Crohn's & colitis.